| Literature DB >> 32077261 |
Kifayat Ullah1, Saima Khan2, Yong-Qing Wang1, Zhi-Hui Zhao1, Peng Cheng1, Basanta Sapkota3, Liang Ren1, Samiullah Khan4, Mujeeb Ur Rehman5, Yuan Xue6.
Abstract
OBJECTIVE: To evaluate and present the effectiveness of this innovatively designed, elastic locking intramedullary nail (ELIN) in fixation of clavicle fractures.Entities:
Keywords: Clavicle; Fractures; Intramedullary nail; Locking; Minimal invasive
Year: 2020 PMID: 32077261 PMCID: PMC7031594 DOI: 10.1111/os.12612
Source DB: PubMed Journal: Orthop Surg ISSN: 1757-7853 Impact factor: 2.071
Cause of injury
| No | Cause of injury | Total patients |
|---|---|---|
| 1 | Sports/ Athletics | 12 |
| 2 | Fall on a surface board | 2 |
| 3 | Car accident | 5 |
| 4 | Motorbike | 6 |
| 5 | Bicycle | 4 |
| 6 | Horse Fall | 2 |
| 7 | Direct hit | 2 |
| 8 | Fall from a tree | 1 |
| 9 | Fall from balcony | 1 |
| 10 | Squeeze against a wall by a trailer | 1 |
| 11 | Stairs fall | 2 |
Figure 1(A) Simulation design diagram of Elastic, Locking, Intramedullary Nail. (B) Patent ELIN.
Figure 2(A) a, b, c, d denotes insertion of the two weber clamps while doing the reduction and insertion of ELIN. (B) a, b, c, d denotes insertion points of the two weber clamps, C denotes antegrade insertion point of ELIN whereas D denotes the retrograde insertion point (during the procedure) and pull out point of ELIN (after the complete healing of the fracture).
Figure 3A Graph showing the Ratio of closed reduction (no incision) and Mini‐opened (small incision 30 mm to 50 mm) in our study.
General information, fracture type, operative information, follow‐up and implant removal time of the patients treated with ELIN (n = 38)
| Number | Age | Sex | Side | Fracture type | OTA Classification | Incision (mm) | Operation time(min) | Blood loss (mL) | Closed reduction | Follow up months | Implants removal time (weeks) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 61 | Male | Right | Lateral 1/3 | A | N | 15 | 10 | Y | 23 | 13 |
| 2 | 56 | Male | Left | Middle 1/3rd | A | N | 30 | 12 | Y | 12 | 13 |
| 3 | 68 | Female | Right | Lateral 1/3 | A | N | 25 | 11 | Y | 8 | 10 |
| 4 | 56 | Female | Right | Middle 1/3rd | A | N | 35 | 8 | Y | 13 | 13 |
| 5 | 46 | Female | Left | Middle 1/3rd | B | N | 20 | 10 | Y | 24 | 15 |
| 6 | 44 | Male | Right | Medial 1/3rd | B | N | 30 | 10 | Y | 32 | 12 |
| 7 | 41 | Male | Left | Middle 1/3rd | B | 30 | 15 | 12 | N | 16 | 13 |
| 8 | 63 | Male | Right | Lateral 1/3 | B | N | 30 | 13 | Y | 12 | 10 |
| 9 | 71 | Female | Left | Middle 1/3rd | A | 50 | 40 | 25 | N | 8 | 10 |
| 10 | 63 | Male | Left | Middle 1/3rd | A | N | 30 | 10 | Y | 17 | 13 |
| 11 | 48 | Male | Right | Medial 1/3rd | A | N | 35 | 14 | Y | 15 | 18 |
| 12 | 41 | Male | Right | Middle 1/3rd | B | N | 25 | 12 | Y | 26 | 10 |
| 13 | 46 | Male | Right | Middle 1/3rd | B | N | 20 | 10 | Y | 19 | 15 |
| 14 | 12 | Male | Right | Middle 1/3rd | A | N | 20 | 15 | Y | 9 | 13 |
| 15 | 36 | Male | Right | Middle 1/3rd | C | 40 | 25 | 20 | N | 33 | 18 |
| 16 | 57 | Male | Right | Lateral 1/3 | A | N | 25 | 13 | Y | 9 | 13 |
| 17 | 73 | Male | Left | Middle 1/3rd | A | 40 | 30 | 16 | N | 10 | 13 |
| 18 | 64 | Male | Right | Middle 1/3rd | A | N | 20 | 12 | Y | 20 | 14 |
| 19 | 62 | Female | Left | Middle 1/3rd | A | N | 15 | 8 | Y | 12 | 16 |
| 20 | 19 | Male | Left | Medial 1/3rd | A | N | 24 | 10 | Y | 12 | 16 |
| 21 | 59 | Female | Right | Middle 1/3rd | B | 40 | 32 | 18 | N | 23 | 13 |
| 22 | 48 | Male | Right | Middle 1/3rd | B | N | 34 | 12 | Y | 25 | 12 |
| 23 | 54 | Male | Left | Middle 1/3rd | A | N | 18 | 8 | Y | 14 | 10 |
| 24 | 60 | Male | Right | Middle 1/3rd | A | N | 24 | 9 | Y | 18 | 13 |
| 25 | 57 | Male | Left | Middle 1/3rd | B | N | 22 | 7 | Y | 13 | 10 |
| 26 | 56 | Female | Right | Middle 1/3rd | B | N | 18 | 8 | Y | 24 | 12 |
| 27 | 61 | Male | Left | Middle 1/3rd | B | N | 16 | 8 | Y | 12 | 15 |
| 28 | 66 | Female | Left | Middle 1/3rd | A | N | 22 | 10 | Y | 8 | 18 |
| 29 | 62 | Male | Left | Middle 1/3rd | B | N | 28 | 18 | Y | 11 | 14 |
| 30 | 67 | Female | Right | Middle 1/3rd | A | N | 32 | 16 | Y | 16 | 16 |
| 31 | 30 | Male | Left | Middle 1/3rd | B | N | 24 | 12 | Y | 12 | 15 |
| 32 | 61 | Female | Left | Middle 1/3rd | C | 50 | 38 | 20 | N | 15 | 17 |
| 33 | 58 | Female | Left | Middle 1/3rd | A | N | 32 | 18 | Y | 19 | 12 |
| 34 | 45 | Female | Right | Medial 1/3rd | A | N | 24 | 16 | Y | 14 | 13 |
| 35 | 53 | Female | Right | Middle 1/3rd | B | N | 20 | 10 | Y | 15 | 15 |
| 36 | 52 | Female | Right | Middle 1/3rd | A | 40 | 26 | 20 | N | 23 | 16 |
| 37 | 51 | Female | Right | Middle 1/3rd | B | N | 25 | 17 | Y | 19 | 14 |
| 38 | 85 | Female | Left | Middle 1/3rd | B | N | 30 | 15 | Y | 16 | 18 |
| AVG | 54 | 41.42857143 | 25.63157895 | 12.97368421 | 16.5 | 13.71052632 | |||||
| SD | 13.94160755 | 6.38876565 | 6.474326027 | 4.220793403 | 6.315186375 | 2.372073208 |
Footnotes: Y = Yes, N = No, OTA = Orthopedic Trauma Association.
Complications, functional outcomes, and cosmetic outcomes of the patients treated with ELIN (n = 38)
| Number | Constant score | DASH Score | Comparison with opposite side | Shortening | Complications | (Scar/No Scar) |
|---|---|---|---|---|---|---|
| 1 | 100 | 0 | Symmetrical | N | None | No Scar |
| 2 | 100 | 0 | Symmetrical | N | Pressure sores | No Scar |
| 3 | 100 | 0 | Symmetrical | N | None | No Scar |
| 4 | 100 | 1 | Symmetrical | N | None | No Scar |
| 5 | 100 | 5 | Symmetrical | N | Skin irritation/protrusion | No Scar |
| 6 | 100 | 0 | Symmetrical | N | None | No Scar |
| 7 | 100 | 0 | Non‐Symmetrical | Y | Pressure sores /Functional Limitation of the shoulder joint | Scar |
| 8 | 100 | 0.8 | Symmetrical | N | None | No Scar |
| 9 | 100 | 0 | Symmetrical | N | None | Scar |
| 10 | 100 | 0.9 | Symmetrical | N | None | No Scar |
| 11 | 100 | 0 | Symmetrical | N | Pressure sores / protrusion | No Scar |
| 12 | 100 | 0 | Symmetrical | N | None | No Scar |
| 13 | 100 | 0 | Symmetrical | N | None | No Scar |
| 14 | 100 | 0 | Symmetrical | N | Pressure sores / local infection | No Scar |
| 15 | 100 | 0 | Symmetrical | N | None | Scar |
| 16 | 100 | 0.8 | Symmetrical | N | None | No Scar |
| 17 | 97 | 3.8 | Symmetrical | N | None | Scar |
| 18 | 100 | 0 | Symmetrical | N | None | No Scar |
| 19 | 96 | 4.2 | Symmetrical | N | None | No Scar |
| 20 | 97 | 2 | Symmetrical | N | None | No Scar |
| 21 | 78 | 5.8 | Non‐Symmetrical | Y | Nail bending | Scar |
| 22 | 100 | 0 | Symmetrical | N | None | No Scar |
| 23 | 95 | 3.8 | Symmetrical | N | Pressure sores / local infection | No Scar |
| 24 | 100 | 0 | Symmetrical | N | None | No Scar |
| 25 | 100 | 8 | Symmetrical | N | Skin erosion/Nail Exposure/ local infection | No Scar |
| 26 | 100 | 0 | Symmetrical | N | None | No Scar |
| 27 | 94 | 4.8 | Symmetrical | N | None | No Scar |
| 28 | 100 | 0 | Non‐Symmetrical | Y | Pressure sores /Functional Limitation of the shoulder joint | No Scar |
| 29 | 96 | 4.2 | Symmetrical | N | None | No Scar |
| 30 | 97 | 1 | Symmetrical | N | None | No Scar |
| 31 | 100 | 0.8 | Symmetrical | N | None | No Scar |
| 32 | 100 | 0 | Symmetrical | N | Pressure sores | Scar |
| 33 | 95 | 3.8 | Symmetrical | N | None | No Scar |
| 34 | 97 | 5.8 | Symmetrical | N | None | No Scar |
| 35 | 100 | 0 | Symmetrical | N | None | No Scar |
| 36 | 100 | 2.5 | Symmetrical | N | Pressure sores /protrusion | Scar |
| 37 | 100 | 0 | Symmetrical | N | None | No Scar |
| 38 | 100 | 0 | Symmetrical | N | Skin irritation/pressure | No Scar |
| AVG | 98.47368421 | 1.552631579 | ||||
| SD | 3.802608814 | 2.184242232 |
Footnotes: Y = Yes, N = No, DASH=disabilities of the arm, shoulder and hand
Figure 4(A) Preoperative x‐ray showing a patient with mid clavicular fracture. (B) x‐ray showing midclavicular fracture treated with ELIN. (C) x‐ray showing the complete healing of the fracture after the removal of ELIN.
Figure 5(A) Preoperative x‐ray showing of a patient with medial 1/3 clavicular fracture preoperative. (B) postoperative x‐ray showing medial 1/3 fracture treated with ELIN. (C) x‐ray showing the complete healing of the fracture after the removal of ELIN.
Figure 6(A) Preoperative x‐ray showing a patient with lateral 1/3 clavicular fracture. (B) postoperative x‐ray showing lateral 1/3 fracture treated with ELIN. (C) x‐ray showing the complete healing of the fracture after the removal of ELIN.
Figure 7Cosmetic results after the removal of ELIN in a male patient aged 30 with middle 1/3 clavicle fracture.
Figure 8Schematic summary of ELIN.